REZOLVE AI LTD (RZLV)

Common Stock

2.4  -0.81 (-25.23%)

After market: 1.94 -0.46 (-19.17%)

Fundamental Rating

1

Overall RZLV gets a fundamental rating of 1 out of 10. We evaluated RZLV against 284 industry peers in the Software industry. RZLV may be in some trouble as it scores bad on both profitability and health. RZLV does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

In the past year RZLV has reported negative net income.
RZLV had a negative operating cash flow in the past year.

1.2 Ratios

RZLV has a Return On Assets of -10.34%. This is in the lower half of the industry: RZLV underperforms 60.57% of its industry peers.
With a Return On Equity value of -26.86%, RZLV is not doing good in the industry: 61.29% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -10.34%
ROE -26.86%
ROIC N/A
ROA(3y)-1.32%
ROA(5y)N/A
ROE(3y)-1.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

RZLV does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, RZLV has less shares outstanding
The debt/assets ratio for RZLV is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 33.31 indicates that RZLV is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 33.31, RZLV belongs to the best of the industry, outperforming 95.70% of the companies in the same industry.
A Debt/Equity ratio of 0.45 indicates that RZLV is not too dependend on debt financing.
RZLV has a worse Debt to Equity ratio (0.45) than 67.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 33.31
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.01 indicates that RZLV may have some problems paying its short term obligations.
RZLV has a worse Current ratio (0.01) than 99.64% of its industry peers.
RZLV has a Quick Ratio of 0.01. This is a bad value and indicates that RZLV is not financially healthy enough and could expect problems in meeting its short term obligations.
RZLV has a worse Quick ratio (0.01) than 99.64% of its industry peers.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01

0

3. Growth

3.1 Past

RZLV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1040.70%.
EPS 1Y (TTM)-1040.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

RZLV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for RZLV!.
Industry RankSector Rank
Dividend Yield N/A

REZOLVE AI LTD

NASDAQ:RZLV (1/13/2025, 8:00:02 PM)

After market: 1.94 -0.46 (-19.17%)

2.4

-0.81 (-25.23%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.55%
Inst Owner ChangeN/A
Ins Owners44.32%
Ins Owner ChangeN/A
Market Cap431.47M
Analysts82.86
Price TargetN/A
Short Float %7.93%
Short Ratio0.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 70.6
P/tB 70.6
EV/EBITDA N/A
EPS(TTM)-0.23
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.34%
ROE -26.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1.32%
ROA(5y)N/A
ROE(3y)-1.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z 33.31
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1040.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y20.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-185.25%
EBIT Next 3Y65.83%
EBIT Next 5YN/A
FCF growth 1Y-23.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-23.58%
OCF growth 3YN/A
OCF growth 5YN/A